Reported about 9 hours ago
Illumina Inc. experienced its worst month in nearly 23 years, with a 33% drop in stock value and a market value loss of about $7 billion amid concerns over President Trump's China tariffs, dismal earnings forecasts, increased competition, and funding cuts. The company's troubles intensified following its blacklisting in China, uncertainty regarding NIH funding, and competitive pressures from new technologies, prompting analysts to lower their ratings and recommendations on the stock. Investors are now apprehensive, awaiting signs of recovery or growth.
Source: YAHOO